Dashboard
Manage Tickers

INTT


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

recap-intest-q4-earnings
Recap: inTest Q4 Earnings
03/27/2024 21:50:07

intest-q4-2023-adj-eps-016-beats-014-estimate-sales-27884m-miss-29152m-estimate
inTest Q4 2023 Adj EPS $0.16 Beats $0.14 E...
03/27/2024 21:46:57

inTest (AMEX:INTT) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 p...

intest-to-restate-q3-and-first-nine-months-2023-financial-statements-expects-to-report-material-weakness-in-its-internal-control-over-financial-reporting
inTEST To Restate Q3 And First Nine Months...
03/12/2024 20:26:40

The restatement pertains to deferral of revenue related to purchases on behalf of certain customers associated with "last t...

intest-updates-full-year-2024-guidance-due-to-alfamation-acquisition-boosts-2024-revenue-outlook-from-125m-130m-to-145m-155m-est-125795m
inTEST Updates Full Year 2024 Guidance Due...
03/12/2024 20:23:52

The acquisition is expected to be dilutive to earnings per diluted share in 2024, but accretive to non-GAAP adjusted EPS due to...

intest-acquires-alfamation-spa-no-terms-disclosed
inTEST Acquires Alfamation S.p.A.; No Term...
03/12/2024 20:19:59

Alfamation will become a part of the Electronic Test division within inTEST. At current exchange rates, Alfamation's annual...

12-information-technology-stocks-moving-in-mondays-after-market-session
12 Information Technology Stocks Moving In...
03/04/2024 21:32:13

intest-prelim-q4-revenue-284m-eps-014-sees-q1-revenue-28m-30m-eps-008-013-co-to-reschedule-q4-earnings-release
inTEST Prelim. Q4 Revenue ~$28.4M, EPS $0....
02/29/2024 22:17:29

intest-delays-q4-2023-earnings-release-says-it-requires-additional-time-to-complete-year-end-audit-and-review-process-preliminary-q4-revenue-284m-est-29152m
inTEST Delays Q4 2023 Earnings Release, Sa...
02/29/2024 22:17:19

earnings-outlook-for-intest
Earnings Outlook For inTest
02/29/2024 14:01:36

12-information-technology-stocks-moving-in-tuesdays-after-market-session
12 Information Technology Stocks Moving In...
12/12/2023 21:30:59

intest-board-approves-stock-repurchase-plan-for-up-to-10m-of-common-stock-through-november-17-2024
inTEST Board Approves Stock Repurchase Pla...
11/27/2023 21:16:24

intest-corp-files-prospectus-for-up-to-100m-offering
inTEST Corp Files Prospectus For Up To $10...
11/09/2023 22:00:22

$100,000,000inTEST CorporationCommon StockPreferred StockWarrantsPurchase ContractsRightsUnitsWe may offer to the public from t...

earnings-scheduled-for-november-3-2023
Earnings Scheduled For November 3, 2023
11/03/2023 11:12:01

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...

intest-sees-q4-revenue-of-28m---30m-vs-324m-est-adj-eps-of-012---017-vs-02-est
inTEST Sees Q4 Revenue Of $28M - $30M Vs. ...
11/03/2023 10:39:46

intest-cuts-fy23-revenue-guidance-from-127m---131m-to-125m---127m-vs-1295m-est
inTEST Cuts FY23 Revenue Guidance From $12...
11/03/2023 10:37:55

intest-q3-adj-eps-028-beats-025-estimate-sales-3266m-beat-3265m-estimate
inTest Q3 Adj EPS $0.28 Beats $0.25 Estima...
11/03/2023 10:35:33

inTest (AMEX:INTT) reported quarterly adjusted earnings of $0.28 per share which beat the analyst consensus estimate of $0.25 b...

preview-intests-earnings
Preview: inTest's Earnings
11/02/2023 18:01:53

intest-corp-expects-q3-revenue-in-line-with-q2-of-326m-vs-3218m-est-adj-eps-023-027-vs-027-est-raised-fy23-revenue-to-127m-131m-prior-125m-130m-vs-12851m-est
inTEST Corp Expects Q3 Revenue In Line Wit...
08/04/2023 10:35:46

intest-q2-adj-eps-028-beats-027-estimate-sales-3256m-beat-3210m-estimate
inTest Q2 Adj EPS $0.28 Beats $0.27 Estima...
08/04/2023 10:31:23

inTest (AMEX:INTT) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.27 by 3.7 per...

earnings-scheduled-for-august-4-2023
Earnings Scheduled For August 4, 2023
08/04/2023 09:30:16

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashan...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION